抗艾药品绥美凯国内有吗

(TRIUMEQ) is a drug for the treatment of AIDS. Trimeq (TRIUMEQ) is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.

TRIUMEQ (dolutegravir, abacavir, or lamivudine) is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or a dose adjustment is required, separate formulations of dolutegravir, abacavir, or lamivudine can be used. In these cases, physicians should refer to the respective product information for these medicines. If the patient misses a dose of TRIUMEQ (TRIUMEQ) and there are more than 4 hours before the next dose, he should take TRIUMEQ as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.

Is the anti-AIDS drug Suimeika available in China? Suimeike (Dolutea Paramid Tablets, Inbec) has been launched in China, and patients can purchase the drug at major domestic regular pharmacies or hospital pharmacies with a prescription issued by a doctor.

Patients taking TRIUMEQ (TRIUMEQ) for treatment should note:

Patients with pre-existing hepatic dysfunction, including those with chronic active hepatitis, develop hepatic dysfunction with increased frequency during combined antiretroviral therapy and should be monitored according to standard protocols. If in these patients there is evidence of worsening liver disease, withholding or discontinuing treatment should be considered.

Treatment with TRIUMEQ may affect your ability to drive and operate machinery. Patients should be informed that dizziness has been reported during treatment with dolutegravir. When considering a patient's ability to drive or operate machinery, the patient's clinical status and the adverse reaction profile of TRIUMEQ should be kept in mind.

Patients who are allergic to any of the ingredients in (TRIUMEQ) should not use this drug for treatment.

Recommended related hot articles: /newsDetail/80720.html